Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 January 2024 | Story Igno van Niekerk | Photo Igno van Niekerk
Tafadzwa Maramura
Dr Tafadzwa Maramura participated in a study on couplepreneurs and ways in which they influence their children to become better entrepreneurs.

After years of hard work, the lonely entrepreneur rode off into the sunset. No family. No one to share the lived experience with. The entrepreneurial journey can be a recipe for loneliness. However, it does not have to be, you can enjoy an entrepreneurial family that leaves a legacy.

Dr Tafadzwa C Maramura, Senior Lecturer in the Department of Public Administration and Management at the UFS participated in a study with Drs Eugine Maziriri (University of Johannesburg), Miston Mapuranga (University of Pretoria), Brighton Nyagadza (Marondera University of Agricultural Sciences) on couplepreneurs and ways in which they influence their children to become better entrepreneurs. The interinstitutional study drew on several fields of expertise and was a fresh addition to the research on access to water that Dr Maramura is doing.

Couplepreneurship is a concept that explains businesses owned and operated by married and/or cohabiting couples. According to Dr Maramura: “The development of couplepreneurship in South Africa as an emerging economy has led to increasing interest in the study of how kids are inspired and/or influenced by their parents towards starting their own and to participate in the already existing family enterprises.”

Nurturing entrepreneurial potential

Couplepreneurs are in a great position to raise kidpreneurs. Who better to listen to the heroic stories of how mom and dad started off with a big dream, growth mindsets, and steadfast commitment to building their business than their offspring? Like teaching a person how to fish rather than giving them fish, couplepreneurs do not hand their kids a business, they teach them how to run and grow a business.

Dr Maramura believes that nurturing an entrepreneurial potential is the result of “encouraging resilience, adaptability, and a willingness to embrace failure, even as a learning opportunity”. Combine this with an environment that promotes creativity, critical thinking, and problem-solving skills, and you have the recipe for a kidpreneur to become an entrepreneur. Now add more ingredients: parents who offer support, mentorship, and exposure to diverse experiences. Put it in the heated oven called business – and you have created the meal all entrepreneurs crave: Legacy.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept